In a paper published by JACS, Qi Zhang, an assistant professor of biochemistry and biophysics and member of the UNC Lineberger Comprehensive Cancer Center, and his team have revealed his newest weapon – a powerful technique to visualize the shape and motion of RNA at the atomic level using nuclear magnetic resonance spectroscopy (NMR).
Congratulations to Dr. Charlie Carter, Professor of Biochemistry and Biophysics, whose publication in the September 13th issue of Journal of Biological Chemistry was selected as one of UNC School of Medicine's top ten stories of the year.
Congratulations to Dr. Wolfgang Bergmeier, Associate Professor of Biochemistry & Biophysics for receiving an Established Investigator Award from the American Heart Association for research on "The Platelet Signaling in Inflammation and Autoimmunity".
In keeping with last year's ranking, the Department continues to rank fourth among all Biochemistry departments in the US.
Learn more about Henrik Dohlman, professor and vice chair of biochemistry and biophysics, from his profile highlight in ASBMB Today's December 2013 issue.
Learn more about the event "Translating the Biophysics of Molecular Switches: Signaling Mechanisms and Inhibition of Ras and Rho GTPases"
Dr. Charles Carter, Jr., Professor of Biochemistry and Biophysics resurrect “molecular fossils” to conduct experiments that undercut the predominant scientific theory of how life began on Earth.
Congratulations to Greg Wang, Assistant Professor of Biochemistry and Biophysics, who was awarded a Jefferson Pilot Fellowship from UNC School of Medicine to further his research mission searching for better ways to shut down cancer cells.
The team from the University of North Carolina at Chapel Hill found that a single atom—a calcium, in fact—can control how bacteria walk.
Congratulations to Dr. Jeanette Cook, Associate Professor of Biochemistry and Biophysics who assumed her new administrative role on Sept. 15, 2013.
A new study in the Parise lab — the first to apply a new screening technique to human platelets — netted a potential drug target for preventing dangerous blood clots in high-risk people.
Researchers from the Dohlman lab have discovered that a well-known associate of G protein-coupled receptors -- a common target of FDA-approved drugs -- may play a critical role in mounting a rescue effort to avert an intracellular meltdown.